Abstract
T cell-redirecting strategies have emerged as effective cancer immunotherapy approaches. Bispecific antibodies (bsAbs) are designed to specifically recruit T cells to the tumor microenvironment and induce the assembly of the immunological synapse (IS) between T cells and cancer cells or antigen-presenting cells. The way that the quality of the IS might predict the effectiveness of T cell-redirecting strategies, including those mediated by bsAbs or by chimeric antigen receptors (CAR)-T cells, is currently under discussion. Here we review the organization of the canonical IS assembled during natural antigenic stimulation through the T cell receptor (TCR) and to what extent different bsAbs induce T cell activation, canonical IS organization, and effector function. Then, we discuss how the biochemical parameters of different formats of bsAbs affect the effectivity of generating an antigen-induced canonical IS. Finally, the quality of the IS assembled by bsAbs and monoclonal antibodies or CAR-T cells are compared, and strategies to improve bsAb-mediated T cell-redirecting strategies are discussed.
Funder
Comunidad de Madrid
Spanish Ministry of Science and Innovation
Carlos III Health Institute
CRIS Cancer Foundation
Spanish Association Against Cancer
Fundación “La Caixa”
Fundación de Investigación Biomédica 12 de Octubre Programa Investiga
Reference90 articles.
1. Bispecific Antibodies: From Research to Clinical Application;Ma;Front. Immunol.,2021
2. Castaman, G., Di Minno, G., De Cristofaro, R., and Peyvandi, F. (2022). The Arrival of Gene Therapy for Patients with Hemophilia A. Int. J. Mol. Sci., 23.
3. A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer’s Disease Mice;Rofo;Neurotherapeutics,2022
4. Bispecific Immunomodulatory Antibodies for Cancer Immunotherapy;Blanco;Clin. Cancer Res.,2021
5. The coming of age of engineered multivalent antibodies;Compte;Drug Discov. Today,2015
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献